JAAD Weighs Methodology Behind Immunotherapy Eruption vs SJS Study
Ling Chen and Zhu Shen critique the case-control design of the JAAD study separating progressive immunotherapy-related mucocutaneous eruption from Stevens-Johnson syndrome, published 14 October 2026.